Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
C3 Biotech is a pioneering synthetic biology company focused on the industrial-scale biomanufacturing of sustainable chemicals and high-energy fuels. Spun out from the Manchester Institute of Biotechnology, the company utilizes a proprietary fermentation platform that operates under non-sterile conditions to significantly reduce capital and operational expenditures. Their technology transforms industrial waste streams and carbon dioxide into drop-in bio-based alternatives for traditionally fossil-derived products like kerosene, LPG, and specialty chemicals. By integrating advanced biological engineering with scalable industrial processes, C3 Biotech aims to decarbonize global manufacturing sectors including aviation, defense, and consumer goods. The company is recognized for its leadership in the UK bioeconomy and maintains strategic partnerships with major industrial and government entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on C3.